P21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Wei, Junxia ^b   Zhao, Jiang ^b   Long, Min ^a   Han, Yuan ^a   Wang, Xi ^a   Lin, Fang ^a   Ren, Jihong ^a   He, Ting ^a   Zhang, Huizhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Xi'an Railway Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DOUBLE STRANDED RNA; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TUMOR XENOGRAFT; UPREGULATION; CANCER TRANSPLANTATION; CARCINOMA; LUNG TUMOR; METABOLISM; METHODOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS, GENETIC; RNA; RNA, DOUBLE-STRANDED; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 78349268381     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-632     Document Type: Article

References (23)

1. Rosell R, Felip E. Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer. Semin Oncol 2001, 28:37-44. 10.1016/S0093-7754(01)90058-2, 11605182.
2. Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L. Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer. Ai Zheng 2004, 23:845-850.
3. Stordal B, Davey M. Understanding cisplatin resistance using cellular models. IUBMB Life 2007, 59:696-699. 10.1080/15216540701636287, 17885832.
4. Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res 2001, 478:23-43.
5. Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T, Lees JA. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci USA 1999, 96:1002-1007. 10.1073/pnas.96.3.1002, 15340, 9927683.
6. Gartel AL, Tyner AL. The growth-regulatory role of p21 (WAF1/CIP1). Prog Mol Subcell Biol 1998, 20:43-71.
7. Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest 2004, 113:160-168. 311439, 14722605.
8. Mooi WJ, Peeper DS. Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med 2006, 355:1037-1046. 10.1056/NEJMra062285, 16957149.
9. Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci USA 2000, 97:9042-9046. 10.1073/pnas.160016897, 16818, 10908655.
10. Giannakakou P, Robey R, Fojo T, Blagosklonny MV. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 2001, 20:3806-3813. 10.1038/sj.onc.1204487, 11439344.
11. Li LC, Okino ST, Zhao H, Pookot D, Place RF, Urakami S, Enokida H, Dahiya R. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 2006, 103:17337-17342. 10.1073/pnas.0607015103, 1859931, 17085592.
12. Chen Z, Place RF, Jia ZJ, Pookot D, Dahiya R, Li LC. Antitumor effect of dsRNA-induced p21WAF1/CIP1 gene activation in human bladder cancer cells. Mol Cancer Ther 2008, 7:698-703. 10.1158/1535-7163.MCT-07-2312, 18347154.
13. Yang K, Zheng XY, Qin J, Wang YB, Bai Y, Mao QQ, Wan Q, Wu ZM, Xie LP. Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett 2008, 265:206-214. 10.1016/j.canlet.2008.02.014, 18358601.
14. Niculescu AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998, 18:629-643. 121530, 9418909.
15. Ogryzko VV, Wong P, Howard BH. WAF1 retards Sphase progression primarily by inhibition of cyclindependent kinases. Mol Cell Biol 1997, 17:4877-4882. 232340, 9234744.
16. Radhakrishnan SK, Feliciano CS, Najmabadi F, Haegebarth A, Kandel ES, Tyner AL. Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle. Oncogene 2004, 23:4173-4176. 10.1038/sj.onc.1207571, 15048076.
17. McDonald ER, Wu GS, Waldman T, El-Deiry WS. Repair defect in p21 WAF1/CIP12/2 human cancer cells. Cancer Res 1996, 56:2250-2255.
18. Abde MA, Ben HP. p21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008, 10:e19. 10.1017/S1462399408000744, 2678956, 18590585.
19. T Waldman C, Lengaue KW, Kinzler B, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996, 381:713-716. 10.1038/381713a0, 8649519.
20. Li WW, Fan J, Hochhauser D, Bertino JR. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells. Cancer Res 1997, 57:2193-2199.
21. Medema RH, Klompmaker R, Smits VA, Rijksen G. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene 1998, 16:431-441. 10.1038/sj.onc.1201558, 9484832.
22. Gartel AL, Radhakrishnan SK. Lost in Transcription: p21 Repression, Mechanisms, and Consequences. Cancer Res 2005, 65:3980-3985. 10.1158/0008-5472.CAN-04-3995, 15899785.
23. Liu SX, Robert Bishop W, Liu M. Differential effects of cell cycle regulatory protein p21WAF1/Cip1 on apoptosis and sensitivity to cancer chemotherapy. Drug Resistance Updates 2003, 6:183-195. 10.1016/S1368-7646(03)00044-X, 12962684.